Pomanda estimates the enterprise value of ARROW GENERICS LIMITED at £0 based on a Turnover of £0 and 1.26x industry multiple (adjusted for size and gross margin).
arrow generics limitedEstimated Valuation
£0
Pomanda estimates the enterprise value of ARROW GENERICS LIMITED at £0 based on an EBITDA of £0 and a 5.31x industry multiple (adjusted for size and gross margin).
arrow generics limitedEstimated Valuation
£15.8k
Pomanda estimates the enterprise value of ARROW GENERICS LIMITED at £15.8k based on Net Assets of £8.9k and 1.78x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Arrow Generics LimitedOverview
Arrow Generics Limited is a live company located in england, WF10 5HX with a Companies House number of 04124572. It operates in the manufacture of basic pharmaceutical products sector, SIC Code 21100. Founded in December 2000, it's largest shareholder is
teva pharma holdings limited
with a 100% stake. Arrow Generics Limited is a mature,
unknown sized company, Pomanda has estimated its turnover at
£0 with
unknown
growth in recent years.
There is insufficient data available to calculate a health check for Arrow Generics Limited. Company Health Check FAQs
Health Rating0out of 5
0 Strong
0 Regular
1 Weak
Size
There is insufficient data available for this Key Performance Indicator!
- - Arrow Generics Limited
- - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- - Arrow Generics Limited
- - Industry AVG
Production
There is insufficient data available for this Key Performance Indicator!
- - Arrow Generics Limited
- - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- - Arrow Generics Limited
- - Industry AVG
Employees
with 1 employees, this is below the industry average (103)
- - Arrow Generics Limited
- - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- - Arrow Generics Limited
- - Industry AVG
Efficiency
There is insufficient data available for this Key Performance Indicator!
- - Arrow Generics Limited
- - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Arrow Generics Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Arrow Generics Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Arrow Generics Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Arrow Generics Limited
- - Industry AVG
Debt Level
There is insufficient data available for this Key Performance Indicator!
- - Arrow Generics Limited
- - Industry AVG
ARROW GENERICS LIMITED financials
EXPORT
Arrow Generics Limited's latest turnover from December 2024 is 0 and the company has net assets of £8.9 thousand. According to their latest financial statements, we estimate that Arrow Generics Limited has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Dec 2024
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Dec 2012
Dec 2011
Dec 2010
Dec 2009
Turnover
67,082
78,855
15,070,493
44,580,043
34,264,871
28,421,948
29,028,730
Other Income Or Grants
Cost Of Sales
48,920
58,076
11,445,553
33,952,090
26,436,644
21,858,135
Gross Profit
18,162
20,779
3,624,940
10,627,953
7,828,227
6,563,813
Admin Expenses
-2,265
4,045
2,978
26,283
-214,698
-41,886
188,534
3,425,360
17,183,399
12,701,547
8,315,107
-3,320,825
Operating Profit
2,265
-4,045
-2,978
-26,283
214,698
60,048
-167,755
199,580
-6,555,446
-4,873,320
-1,751,294
3,320,825
Interest Payable
56,901
114,523
141,561
175,963
173,923
194,874
227,963
218,503
188,552
46,796
350
36,015
Interest Receivable
23,998
7,701
5,939
6,809
37,894
Pre-Tax Profit
-54,636
-118,568
-144,539
-202,246
40,775
-134,826
134,132
-2,224,649
-6,736,296
-4,914,177
-1,744,835
3,322,704
Tax
-15,613
13,586
69,064
-68,280
569,134
-191,015
1,351,679
453,681
-938,698
Profit After Tax
-54,636
-118,568
-144,539
-217,859
54,361
-65,762
65,852
-1,655,515
-6,927,311
-3,562,498
-1,291,154
2,384,006
Dividends Paid
Retained Profit
-54,636
-118,568
-144,539
-217,859
54,361
-65,762
65,852
-1,655,515
-6,927,311
-3,562,498
-1,291,154
2,384,006
Employee Costs
892,091
2,023,922
1,505,981
1,259,870
1,465,968
Number Of Employees
1
1
1
1
1
1
1
1
1
1
1
13
24
23
19
17
EBITDA*
2,265
-4,045
-2,978
-26,283
214,698
60,048
-132,601
444,649
-6,455,373
-4,644,180
-1,525,565
3,534,651
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2024
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Dec 2012
Dec 2011
Dec 2010
Dec 2009
Tangible Assets
35,154
347,667
429,411
489,512
140,447
Intangible Assets
120,842
281,966
Investments & Other
Debtors (Due After 1 year)
366,000
366,000
100,000
100,000
Total Fixed Assets
35,154
713,667
795,411
710,354
522,413
Stock & work in progress
7,952,513
6,467,345
3,831,765
6,379,103
Trade Debtors
39,763
48,489
46,500
1,616
8,947,556
9,322,653
5,667,360
6,632,409
Group Debtors
8,865
8,865
8,865
8,865
8,865
40,886
39,625
158,226
805,393
1,993,248
1,847,829
785,968
262,535
Misc Debtors
92,599
64,825
130,541
402,485
374,893
416,250
168,410
261,263
Cash
11,115
14,145
18,901
83,804
6,833
19,110
36,118
3,146,230
920,532
2,170,930
1,260,751
misc current assets
total current assets
8,865
8,865
8,865
8,865
8,865
11,115
14,145
18,901
257,052
159,772
354,377
1,245,612
22,414,440
18,974,609
12,624,433
14,796,061
total assets
8,865
8,865
8,865
8,865
8,865
11,115
14,145
18,901
257,052
159,772
354,377
1,280,766
23,128,107
19,770,020
13,334,787
15,318,474
Bank overdraft
Bank loan
Trade Creditors
4,515
3,499
5,277
34,796
17,123
16,795
2,732
1,635,198
407,017
1,315,207
346,810
Group/Directors Accounts
5,018,460
4,903,938
4,762,377
4,518,075
36,354
379,412
313,584
3,880,073
5,433,751
2,614,597
4,025,972
other short term finances
hp & lease commitments
other current liabilities
65,062
8,102
169,007
876,896
10,056,681
3,062,563
2,012,912
2,278,110
total current liabilities
5,022,975
4,907,437
4,767,654
4,617,933
61,579
565,214
1,193,212
15,571,952
8,903,331
5,942,716
6,650,892
loans
4,177,434
3,556,507
3,533,739
10,576,826
7,000,000
hp & lease commitments
Accruals and Deferred Income
other liabilities
provisions
170,013
506,014
752,149
1,139,160
total long term liabilities
170,013
4,683,448
4,308,656
4,672,899
10,576,826
7,000,000
total liabilities
5,022,975
4,907,437
4,767,654
4,787,946
4,745,027
4,873,870
5,866,111
26,148,778
15,903,331
5,942,716
6,650,892
net assets
8,865
8,865
8,865
8,865
8,865
-5,011,860
-4,893,292
-4,748,753
-4,530,894
-4,585,255
-4,519,493
-4,585,345
-3,020,671
3,866,689
7,392,071
8,667,582
total shareholders funds
8,865
8,865
8,865
8,865
8,865
-5,011,860
-4,893,292
-4,748,753
-4,530,894
-4,585,255
-4,519,493
-4,585,345
-3,020,671
3,866,689
7,392,071
8,667,582
Dec 2024
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Dec 2012
Dec 2011
Dec 2010
Dec 2009
Operating Activities
Operating Profit
2,265
-4,045
-2,978
-26,283
214,698
60,048
-167,755
199,580
-6,555,446
-4,873,320
-1,751,294
3,320,825
Depreciation
35,154
245,069
100,073
108,298
64,605
52,703
Amortisation
120,842
161,124
161,123
Tax
-15,613
13,586
69,064
-68,280
569,134
-191,015
1,351,679
453,681
-938,698
Stock
-7,952,513
1,485,168
2,635,580
-2,547,338
6,379,103
Debtors
8,865
-173,248
20,309
-182,328
-874,227
-10,472,203
-271,035
5,230,994
-534,469
7,256,207
Creditors
-4,515
1,016
-1,778
-29,519
17,673
328
14,063
-1,632,466
1,228,181
-908,190
968,397
346,810
Accruals and Deferred Income
-65,062
56,960
-160,905
-707,889
-9,179,785
6,994,118
1,049,651
-265,198
2,278,110
Deferred Taxes & Provisions
-170,013
-336,001
-246,135
-387,011
1,139,160
Cash flow from operations
-11,115
-3,029
-4,756
-133,242
-53,393
-95,272
-407,491
9,765,408
361,778
-11,017,614
2,713,122
-8,414,437
Investing Activities
capital expenditure
67,444
-18,329
-48,197
-413,670
-636,239
Change in Investments
cash flow from investments
67,444
-18,329
-48,197
-413,670
-636,239
Financing Activities
Bank loans
Group/Directors Accounts
-5,018,460
114,522
141,561
244,302
4,481,721
-343,058
65,828
-3,566,489
-1,553,678
2,819,154
-1,411,375
4,025,972
Other Short Term Loans
Long term loans
-4,177,434
620,927
22,768
-7,043,087
3,576,826
7,000,000
Hire Purchase and Lease Commitments
other long term liabilities
share issue
5,075,361
90,841
39,951
37,116
15,643
6,283,576
interest
-56,901
-114,523
-141,561
-175,963
-173,923
-194,874
-227,963
-194,505
-180,851
-40,857
6,459
1,879
cash flow from financing
-1
68,339
130,364
82,995
-139,367
-10,713,240
1,882,248
9,815,413
-1,389,273
10,311,427
cash and cash equivalents
cash
-11,115
-3,030
-4,756
-64,903
76,971
-12,277
-17,008
-3,110,112
2,225,698
-1,250,398
910,179
1,260,751
overdraft
change in cash
-11,115
-3,030
-4,756
-64,903
76,971
-12,277
-17,008
-3,110,112
2,225,698
-1,250,398
910,179
1,260,751
arrow generics limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for arrow generics limited. Get real-time insights into arrow generics limited's credit score, group structure and payment trends.
Perform a competitor analysis for arrow generics limited by selecting its closest rivals, whether from the MANUFACTURING sector, other mature companies, companies in WF10 area or any other competitors across 12 key performance metrics.
arrow generics limited Ownership
ARROW GENERICS LIMITED group structure
Arrow Generics Limited has no subsidiary companies.
The sole shareholder of Arrow Generics Limited is Teva Pharma Holdings Limited.
teva pharma holdings limited
100%
arrow generics limited directors
Arrow Generics Limited currently has 2 directors.
The longest serving directors include
Mr Dean Cooper (Jul 2018) and
Mr Stephen Charlesworth (Apr 2020).
21100 - Manufacture of basic pharmaceutical products
incorporation date
December 2000
age
25
incorporated
UK
ultimate parent company
TEVA PHARMACEUTICAL INDUSTRIES LTD
accounts
Dormant
last accounts submitted
December 2024
previous names
arrow pharmaceuticals limited (May 2001)
hamsard 2251 limited (March 2001)
accountant
-
auditor
-
address
ridings point whistler drive, castleford, england, WF10 5HX
Bank
BARCLAYS BANK PLC
Legal Advisor
-
arrow generics limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 3 charges/mortgages relating to arrow generics limited. Currently there are 3 open charges and 0 have been satisfied in the past.
arrow generics limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for ARROW GENERICS LIMITED. This can take several minutes, an email will notify you when this has completed.
arrow generics limitedCompanies House Filings - See Documents
